Essential Psychopharmacology Volume 4

Essential Psychopharmacology Volume 4 is organized by Hatherleigh Medical Education.

Target Audience:
The primary target audience for this program includes, but is not limited to: addiction treatment professionals, primary care physicians, psychiatrists, psychiatric nurses, clinical psychologists, pharmacists, and social workers. Clinicians who have caseloads composed significantly of individuals with psychiatric disorders, comorbid medical illnesses with substance use and addictive disorders will find this course particularly useful.

Credits: CE/CME Hours: 10

Course Curriculum:
• Opioid Use Disorder: A Review of Medication-Assisted Treatment and Psychosocial Programs
• The Role of Long-Acting Injectable Antipsychotics in Schizophrenia
• Synthetic Cathinone and Cannabinoid Designer Drugs
• PTSD: Overview and DSM-5 Changes
• Attention-Deficit Hyperactivity Disorder: Overview and DSM-5 Changes

Overall Objective: 
The objective of this continuing medical education program is to present participants with an expanded clinical skill set and raised awareness of clinically relevant issues in their profession. They will review key diagnostic criteria, cutting-edge treatment strategies, and practice points they can implement in the challenges of daily practice while providing evidence-based care to patients and clients suffering with chronic pain. The expected outcomes include an increase in knowledge, competence, professionalism, and performance.